These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 10421398

  • 1. Low level wild-type and pre-core mutant hepatitis B viruses and HBeAg negative reactivation of chronic hepatitis B.
    Oketani M, Oketani K, Xiaohong C, Arima T.
    J Med Virol; 1999 Aug; 58(4):332-7. PubMed ID: 10421398
    [Abstract] [Full Text] [Related]

  • 2. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
    Watanabe K, Takahashi T, Takahashi S, Okoshi S, Ichida T, Aoyagi Y.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
    Cabrerizo M, Bartolomé J, Iñigo ER, López-Alcorocho JM, Cotonat T, Carreño V.
    J Med Virol; 1998 Dec; 56(4):294-9. PubMed ID: 9829632
    [Abstract] [Full Text] [Related]

  • 5. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ, Yoo BC.
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [Abstract] [Full Text] [Related]

  • 6. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
    Niitsuma H, Ishii M, Miura M, Kobayashi K, Toyota T.
    Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
    [Abstract] [Full Text] [Related]

  • 7. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
    Maruyama T, Mitsui H, Maekawa H, Yamada H, Hirayama M, Iino S, Yasuda K, Koike K, Kimura S, Milich DR.
    Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [Abstract] [Full Text] [Related]

  • 9. Response of pre-core mutant chronic hepatitis B infection to lamivudine.
    Rizzetto M, Volpes R, Smedile A.
    J Med Virol; 2000 Jul; 61(3):398-402. PubMed ID: 10861653
    [Abstract] [Full Text] [Related]

  • 10. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.
    Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ.
    Am J Gastroenterol; 2003 Oct; 98(10):2261-7. PubMed ID: 14572577
    [Abstract] [Full Text] [Related]

  • 11. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.
    Chu CM, Chen YC, Tai DI, Liaw YF.
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):535-40. PubMed ID: 20304099
    [Abstract] [Full Text] [Related]

  • 12. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B.
    Yuen MF, Ng IO, Fan ST, Yuan HJ, Wong DK, Yuen JC, Sum SS, Chan AO, Lai CL.
    Am J Gastroenterol; 2004 Oct; 99(10):2032-7. PubMed ID: 15447768
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus genotypes and precore/core-promoter mutations in Tunisian patients with chronic hepatitis B virus infection.
    Ayed K, Gorgi Y, Ayed-Jendoubi S, Aouadi H, Sfar I, Najjar T, Ben Abdallah T.
    J Infect; 2007 Mar; 54(3):291-7. PubMed ID: 16911832
    [Abstract] [Full Text] [Related]

  • 14. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
    Zampino R, Marrone A, Karayiannis P, Cirillo G, del Giudice EM, Rania G, Utili R, Ruggiero G.
    Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268
    [Abstract] [Full Text] [Related]

  • 15. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
    Kuwahara R, Kumashiro R, Murashima S, Ogata K, Tanaka K, Hisamochi A, Hino T, Ide T, Tanaka E, Koga Y, Sata M.
    J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients].
    Deal C, Ajana F, Canva V, Mouton Y, Yazdanpanah Y, Wattré P, Bocket L.
    Ann Biol Clin (Paris); 2002 Jan; 60(5):581-8. PubMed ID: 12368144
    [Abstract] [Full Text] [Related]

  • 17. Presence of hepatitis B virus core promoter mutations pre-seroconversion predict persistent viral replication after HBeAg loss.
    Ferns RB, Naoumov NV, Gilson RJ, Tedder RS.
    J Clin Virol; 2007 Jul; 39(3):199-204. PubMed ID: 17526429
    [Abstract] [Full Text] [Related]

  • 18. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
    Kumar M, Chauhan R, Gupta N, Hissar S, Sakhuja P, Sarin SK.
    Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
    [Abstract] [Full Text] [Related]

  • 19. Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia.
    Bozkaya H, Yurdaydin C, Idilman R, Tüzün A, Cinar K, Erkan O, Bozdayi AM, Erden E, Uzun Y, Cetinkaya H, Uzunalimoglu O.
    Antivir Ther; 2005 Apr; 10(2):319-25. PubMed ID: 15865226
    [Abstract] [Full Text] [Related]

  • 20. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.